Page last updated: 2024-09-02

ecteinascidin 743 and Animal Mammary Carcinoma

ecteinascidin 743 has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colombo, T; D'Incalci, M; Donald, S; Falcioni, C; Gescher, AJ; Greaves, P; Jimeno, J; Manson, MM; Steward, WP; Verschoyle, RD; Zaffaroni, M; Zucchetti, M	1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Animal Mammary Carcinoma

Article	Year
Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma. International journal of cancer, 2004, Oct-10, Volume: 111, Issue:6 Topics: Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Antioxidants; Chemoprevention; Diet; Dioxoles; Female; Indoles; Isoquinolines; Liver; Mammary Neoplasms, Animal; Neoplasms, Experimental; Rats; Rats, Wistar; Tetrahydroisoquinolines; Trabectedin	2004

Article

Year

Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma.

International journal of cancer, 2004, Oct-10, Volume: 111, Issue:6

Topics: Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Antioxidants; Chemoprevention; Diet; Dioxoles; Female; Indoles; Isoquinolines; Liver; Mammary Neoplasms, Animal; Neoplasms, Experimental; Rats; Rats, Wistar; Tetrahydroisoquinolines; Trabectedin

2004